JCJefferson Chan

Jefferson Chan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jefferson Chan has a total of 238 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • 19F Activity-Based Barcoding Enables Simultaneous Measurement of pH and Analyte Reactivity

    by Suritra Bandyopadhyay, Laura B. Bickart, Gassan Abudayeh, Shreyan Majumdar, Mia Farraday, Bradley P. Sutton, Jefferson Chan

    Activity-based sensing (ABS) probes are designed to report on analyte activity, but their readouts are often influenced by local pH. Because both probe response and analyte reactivity can vary across physiological pH ranges, signal changes can reflect altered chemistry rather than differences in analyte abundance. Here, we present a 19F magnetic resonance imaging (MRI) platform that converts analyte activation into a pH-dependent chemical shift barcode, enabling simultaneous assignment of both properties within a single measurement. Using nuclear magnetic resonance spectroscopy and MRI, we achieve accurate pH mapping across a broad physiological range and show that F-pHOx, an H2O2-responsive probe, enables quantitative inference of hydrogen peroxide activity across varying pH conditions. We further demonstrate its performance in an ex vivo mouse stomach model, which is a complex environment exhibiting substantial pH heterogeneity. Importantly, the modular fluorophenol reporter is compatible with diverse ABS triggers. This strategy reveals how environmental conditions can influence apparent chemical activity, which is often overlooked.

  • Metabolic Trojan Horse: Multivalent Glucose Ligand Modified Near-Infrared-Absorbing Gold Nanorods for Targeted Photothermal Therapy

    by Chang Jiang, Suritra Bandyopadhyay, Maegen Kincanon, Anita Wo, Emily McQueen Tedford, Amanda K. East, Marsophia Marcellus, Catherine J. Murphy, Jefferson Chan

    Nanoparticle-based photothermal therapy (PTT) provides localized tumor ablation but remains limited by off-target accumulation and the need for high systemic doses. To address these challenges, we developed gold nanorods (AuNRs) coated with a multivalent glucose ligand (mvGlu-AuNR) that engages glucose transporter type 1 (GLUT1) for selective tumor delivery. This design leverages the Warburg effect, using GLUT1 as a metabolic Trojan horse to enter glycolytic cancer cells. In 4T1 breast cancer models, mvGlu-AuNR showed an 8-fold increase in gold content and a 3-fold rise in photoacoustic signal compared to nontargeted controls. Notably, mvGlu-AuNRs converted light to heat more efficiently than mPEG-AuNRs under identical irradiation conditions. ICP-MS analysis confirmed tumor-to-liver ratios ranging from 1.56 to 4.88, which is consistent with strong tumor localization and minimal hepatic uptake. At a systemic dose of 1 mg/kg, mvGlu-AuNRs enabled efficient tumor heating and slowed tumor growth without signs of off-target toxicity. These findings establish metabolic targeting as an effective strategy to enhance PTT specificity, reduce off-target exposure, and enable markedly lower gold dosing.


  • Donor-PeT Control of Intersystem Crossing Enables ALDH1A1-Activated Photodynamic Therapy

    by Joseph A. Forzano, Suritra Bandyopadhyay, Musa Dirak, Sharath C. Mallojjala, Catharine J. Brady, Brennen M. Thomas, Jennifer S. Hirschi, Jefferson Chan

    Aldehyde dehydrogenase 1A1 (ALDH1A1) is highly expressed in therapy-resistant and metastatic cancers and represents a clinically relevant biomarker for selective activation strategies. We report AAP, an OFF-ON photosensitizer activated through ALDH1A1-mediated oxidation that produces singlet oxygen upon light exposure. AAP uses a donor photoinduced electron transfer (d-PeT) mechanism to suppress intersystem crossing in its unreacted benzaldehyde form, which minimizes background activity. Oxidation by ALDH1A1 disrupts d-PeT and restores phototoxicity. AAP showed minimal off-target activation by other ALDH isoforms or oxidative stress. In vivo, AAP suppressed tumor growth in two non-small cell lung cancer (NSCLC) models. In the first, intratumoral delivery into established tumors confirmed efficacy and ALDH1A1 dependence. In the second, liposomal AAP enabled intravenous delivery to early stage lesions with limited vascularization where treatment remained effective. These findings establish d-PeT suppression of intersystem crossing as an effective chemical biology strategy for enzyme-activated photodynamic therapy.


  • Open Access

    Activity-based sensing reveals elevated labile copper promotes liver aging via hepatic ALDH1A1 depletion

    by Zhenxiang Zhao, Melissa Y. Lucero, Shengzhang Su, Eric J. Chaney, Jiajie Jessica Xu, Michael Myszka, Jefferson Chan

    Oxidative stress plays a key role in aging and related diseases, including neurodegeneration, cancer, and organ failure. Copper (Cu), a redox-active metal ion, generates reactive oxygen species (ROS), and its dysregulation contributes to aging. Here, we develop activity-based imaging probes for the sensitive detection of Cu(I) and show that labile hepatic Cu activity increases with age, paralleling a decline in ALDH1A1 activity, a protective hepatic enzyme. We also observe an age-related decrease in hepatic glutathione (GSH) activity through noninvasive photoacoustic imaging. Using these probes, we perform longitudinal studies in aged mice treated with ATN-224, a Cu chelator, and demonstrate that this treatment improves Cu homeostasis and preserves ALDH1A1 activity. Our findings uncover a direct link between Cu dysregulation and aging, providing insights into its role and offering a therapeutic strategy to mitigate its effects.


  • Open Access

    Logic-gated approach for targeted delivery and site-selective activation of photothermal agents in precision cancer treatment

    by Chang Jiang, Zhengxiang Zhao, Amanda K. East, Suritra Bandyopadhyay, Ziyi Jiang, Jefferson Chan

    Logic-gated strategies represent a promising approach to achieving highly selective cancer therapies.


  • Open Access

    Activatable Porphyrin-Based Sensors, Photosensitizers and Combination Therapeutics

    by Suritra Bandyopadhyay, Joseph A Forzano, Musa Dirak, Jefferson Chan

    Porphyrins, known as the "pigments of life", have evolved from their natural roles into versatile tools for biomedical applications. The development of activatable porphyrins has significantly expanded their utility, enabling precise responses to a carefully selected target analyte. These advances have broadened their use in imaging, diagnosis, and therapy. These capabilities are driven by activity-based sensing (ABS), which enhances the selectivity and sensitivity to various disease biomarkers. However, their design and implementation are intrinsically complex. This perspective provides an easy-to-follow roadmap that details how such molecules can be developed. Furthermore, we highlight recent progress in ABS-modified porphyrins, focusing on how specific modifications achieve these remarkable properties across various biomedical platforms. The ongoing evolution of activatable porphyrins holds great promise for the development of sophisticated, responsive systems, offering more effective diagnostic and therapeutic tools.


  • Open Access

    Activity-Based Bioluminescent Logic-Gate Probe Reveals Crosstalk Between the Inflammatory Tumor Microenvironment and ALDH1A1 in Cancer Cells

    by Chelsea B. Swartchick, Musa Dirak, Lily C. F. Wenger, Rodrigo Tapia Hernandez, Michael C. Lee, Jefferson Chan

    Cancer cells with high expression of aldehyde dehydrogenase 1A1 (ALDH1A1) are more resistant to chemotherapy, contribute to tumor progression, and are associated with poor clinical outcomes. ALDH1A1 plays a critical role in protecting cells from reactive aldehydes and, in the case of stem cells, regulates their differentiation through the retinoic acid signaling pathway. Despite the importance of this enzyme, methods to study ALDH1A1 high-expressing cancer cells in vivo remain limited. In this work, we developed AlDeLuc, the first logic-gated bioluminescence probe designed to selectively evaluate ALDH1A1 activity in tumor cells. The probe is sequentially activated by acidic intracellular compartments (i.e., endosomes) and ALDH1A1, ensuring precise detection of ALDH1A1 high-expressing cells and minimizing off-target detection of non-ALDH1A1 cells. Beyond demonstrating efficacy in multiple cancer cell lines and a murine model of breast cancer, we employed AlDeLuc to investigate how the population of ALDH1A1 high-expressing cells is influenced by the inflammatory status of a tumor in the context of a high-fat diet. These findings establish a molecular link between obesity, inflammation, and tumor progression.


  • Exploring Biliverdin’s Molecular Interactions with Cu- and Fe-Based MOFs: A Unified In Vitro Study with Photoacoustic Analysis

    by Hamideh R. Alanagh, Parinaz Fathi, Hailey J. Knox, Parikshit Moitra, Jefferson Chan, Dipanjan Pan

    Metal-organic frameworks (MOFs) have shown promise in enhancing the stability of biomolecules. Herein, biliverdin (BVD), a photoacoustic (PA) and fluorescent agent, was immobilized within the pores of NH2-MIL-101 (Fe) (FeMOFs) and on the surface of CuBTC crystallites (CuMOFs). MOFs were found to enhance the fluorescence emission and quench the PA intensity of biliverdin. Fluorescence and PA studies, in tandem with DFT simulations, demonstrated that the spectral interactions between MOFs and BVD resulted from interactions between biliverdin and the MOF pores and surfaces in addition to alterations in the HOMO-LUMO energy gap. The MOF internal structure of the MOF played a role in BVD loading, with the FeMOFs enabling greater BVD encapsulation, while CuMOF interactions with BVD primarily took place on the MOF surface. The role of these surface vs pore interactions in the release of biliverdin was explored. This study demonstrates that the effects of the MOF internal structure, surface interactions, and energy interactions should be taken into consideration for biomolecule loading in MOFs.


  • Activity-Based Nitric Oxide-Responsive Porphyrin for Site-Selective and Nascent Cancer Ablation

    by Suritra Bandyopadhyay, Zhenxiang Zhao, Amanda K. East, Rodrigo Tapia Hernandez, Joseph A. Forzano, Benjamin A. Shapiro, Anuj K. Yadav, Chelsea B. Swartchick, Jefferson Chan

    Nitric oxide (NO) generated within the tumor microenvironment is an established driver of cancer progression and metastasis. Recent efforts have focused on leveraging this feature to target cancer through the development of diagnostic imaging agents and activatable chemotherapeutics. In this context, porphyrins represent an extraordinarily promising class of molecules, owing to their demonstrated use within both modalities. However, the remodeling of a standard porphyrin to afford a responsive chemical that can distinguish elevated NO from physiological levels has remained a significant research challenge. In this study, we employed a photoinduced electron transfer strategy to develop a panel of NO-activatable porphyrin photosensitizers (NOxPorfins) augmented with real-time fluorescence monitoring capabilities. The lead compound, NOxPorfin-1, features an o-phenylenediamine trigger that can effectively capture NO (via N2O3) to yield a triazole product that exhibits a 7.5-fold enhancement and a 70-fold turn-on response in the singlet oxygen quantum yield and fluorescence signal, respectively. Beyond demonstrating excellent in vitro responsiveness and selectivity toward NO, we showcase the potent photodynamic therapy (PDT) effect of NOxPorfin-1 in murine breast cancer and human non-small cellular lung cancer cells. Further, to highlight the in vivo efficacy, two key studies were executed. First, we utilized NOxPorfin-1 to ablate murine breast tumors in a site-selective manner without causing substantial collateral damage to healthy tissue. Second, we established a nascent human lung cancer model to demonstrate the unprecedented ability of NOxPorfin-1 to halt tumor growth and progression completely. The results of the latter study have tremendous implications for applying PDT to target metastatic lesions.


  • Open Access

    Optical imaging probes for selective detection of butyrylcholinesterase

    by Musa Dirak, Jefferson Chan, Safacan Kolemen

    Butyrylcholinesterase (BChE) is a human serine hydrolase, which plays critical roles in various physiological and pathological states. Here, we summarized the optical probes that can selectively monitor the BChE activity in different biological models.